The EU announces a Team Europe investment in health of almost €170 million in Africa
The planned investments include €6.5 million from the European Commission to expand sustainable pathogen genomics capacity across Members of the African Union and more than €30 million for research supporting areas including clinical research and pandemic preparedness. The European Commission also confirms its investment of €7.5 million to strengthen health resilience in the Democratic Republic of Congo.
EU Member States are also stepping up their investments. France extends its support to epidemic threat surveillance with €2.5 million. Germany is providing €20 million to catalyse investment in African small medium enterprises active in the health sector and value chains, including local manufacturing of medicines and vaccines. Sweden is providing €3.4 million to support continued access to sexual and reproductive health products, while the Netherlands is investing €99 million in an HIV/AIDS programme covering six Southern African countries and neighbouring areas.
Since 2021, Africa and Europe have accelerated their partnership on health through five interconnected thematic areas: manufacturing and access to vaccines, medicines and health technologies (MAV+), sexual and reproductive health and rights, sustainable health security, digital health, and support for public health institutes